Gaois

Search direction

Search mode

Filter results

Collections

5 results in 3 documents

  1. #741525

    Ba cheart na rialacha is infheidhme maidir le feistí a ailíniú, nuair is iomchuí, leis an gCreat Nua Reachtaíochta chun Táirgí a Mhargú arb é atá ann Rialachán (CE) Uimh. 765/2008 ó Pharlaimint na hEorpa agus ón gComhairle [17] agus Cinneadh Uimh. 768/2008/CE ó Pharlaimint na hEorpa agus ón gComhairle [18]

    The rules applicable to devices should be aligned, where appropriate, with the New Legislative Framework for the Marketing of Products, which consists of Regulation (EC) No 765/2008 of the European Parliament and of the Council [17] and Decision No 768/2008/EC of the European Parliament and of the Council [18].

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  2. #741527

    Is iomchuí oibleagáidí ginearálta na n-oibreoirí eacnamaíocha ar leith, lena n-áirítear allmhaireoirí agus dáileoirí, lena bhforbraítear an Creat Nua Reachtaíochta chun Táirgí a Mhargú a leagan amach go soiléir, gan dochar do na hoibleagáidí sonracha a leagtar síos i gcodanna éagsúla an Rialacháin seo, chun an tuiscint ar na ceanglais a leagtar síos sa Rialachán seo a fheabhsú, agus, dá bharr sin, a áirithiú go gcomhlíonfaidh na hoibreoirí na ceanglais sin ar bhealach níos fearr.

    It is appropriate to set out clearly the general obligations of the different economic operators, including importers and distributors, building on the New Legislative Framework for the Marketing of Products, without prejudice to the specific obligations laid down in the various parts of this Regulation, to enhance understanding of the requirements laid down in this Regulation and thus to improve regulatory compliance by the relevant operators.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  3. #745380

    Ba cheart na rialacha is infheidhme maidir le feistí a ailíniú, nuair is iomchuí, leis an gCreat Nua Reachtaíochta chun Táirgí a Mhargú arb é atá ann Rialachán (CE) Uimh. 765/2008 ó Pharlaimint na hEorpa agus ón gComhairle [8] agus Cinneadh Uimh. 768/2008/CE ó Pharlaimint na hEorpa agus ón gComhairle [9].

    The rules applicable to devices should be aligned, where appropriate, with the New Legislative Framework for the Marketing of Products, which consists of Regulation (EC) No 765/2008 of the European Parliament and of the Council [8] and Decision No 768/2008/EC of the European Parliament and of the Council [9].

    Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )

  4. #745382

    Is iomchuí oibleagáidí ginearálta na n-oibreoirí eacnamaíocha ar leith, lena n-áirítear allmhaireoirí agus dáileoirí, lena bhforbraítear an Creat Nua Reachtaíochta chun Táirgí a Mhargú a leagan amach go soiléir, gan dochar do na hoibleagáidí sonracha a leagtar síos i gcodanna éagsúla an Rialacháin seo, chun an tuiscint ar na ceanglais a leagtar síos sa Rialachán seo a fheabhsú, agus, dá bharr sin, a áirithiú go gcomhlíonfaidh na hoibreoirí ábhartha na ceanglais sin ar bhealach níos fearr.

    It is appropriate to set out clearly the general obligations of the different economic operators, including importers and distributors, building on the New Legislative Framework for the Marketing of Products, without prejudice to the specific obligations laid down in the various parts of this Regulation, to enhance understanding of the requirements laid down in this Regulation and thus to improve regulatory compliance by the relevant operators.

    Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )

  5. #2202481

    Mar chuid de reachtaíocht chomhchuibhithe an Aontais, ba cheart na rialacha maidir le córais intleachta saorga ardriosca a chur ar an margadh, a chur i mbun seirbhíse nó a úsáid a leagan síos i gcomhréir le Rialachán (CE) Uimh. 765/2008 ó Pharlaimint na hEorpa agus ón gComhairle lena leagtar amach na ceanglais maidir le creidiúnú agus maidir le faireachas margaidh a bhaineann le táirgí a mhargú, Cinneadh Uimh. 768/2008/CE ó Pharlaimint na hEorpa agus ón gComhairle maidir le creat comhchoiteann chun táirgí a mhargú agus Rialachán (AE) 2019/1020 ó Pharlaimint na hEorpa agus ón gComhairle maidir le faireachas margaidh ar tháirgí agus comhlíonadh táirgí (‘Creat Reachtach Nua chun Táirgí a Mhargú’).

    As part of Union harmonisation legislation, rules applicable to the placing on the market, putting into service and use of high-risk AI systems should be laid down consistently with Regulation (EC) No 765/2008 of the European Parliament and of the Council setting out the requirements for accreditation and the market surveillance of products, Decision No 768/2008/EC of the European Parliament and of the Council on a common framework for the marketing of products and Regulation (EU) 2019/1020 of the European Parliament and of the Council on market surveillance and compliance of products (‘New Legislative Framework for the marketing of products’).

    Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS